Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
基本信息
- 批准号:9523793
- 负责人:
- 金额:$ 34.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-03 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AKT Signaling PathwayAcute Renal Failure with Renal Papillary NecrosisAffectAnti-Bacterial AgentsAntibiotic ResistanceAntibioticsBacteremiaCaringCellsCessation of lifeDataDefense MechanismsDiabetes MellitusDiseaseEpithelial CellsFoundationsGenetic TranscriptionGoalsHealthHost DefenseHumanHyperglycemiaImmuneImpairmentIn VitroInfectionInfection preventionInsulinInsulin ReceptorInsulin ResistanceInsulin Signaling PathwayIntercalated CellKidneyKnowledgeLaboratoriesLinkMediatingModelingMusNon-Insulin-Dependent Diabetes MellitusOutcomePI3K/AKTPancreatic ribonucleasePhosphotransferasesPlayPrediabetes syndromePredispositionProcessProductionPropertyPublishingRegulationResearchRibonucleasesRiskRoleSiteStreamTransgenic MiceTransgenic OrganismsUrinary tractUrinary tract infectionUropathogenUropathogenic E. coliUrotheliumVertebratesantimicrobialantimicrobial peptidebactericidediabetic patientexperimental studyfightinghumanized mouseimprovedin vivoinsightinsulin signalingkidney infectionmicrobialmouse modelnovelnovel therapeuticspreventrenal abscessurinary
项目摘要
ABSTRACT
Diabetes mellitus is a systemic disorder that increases infection susceptibility. The most common site of infection is the
urinary tract. Urinary tract infection (UTI) is more common, more severe, and has worse outcomes in people with
diabetes. To date, the mechanisms that predispose people with diabetes to UTI have not been elucidated. This project will
evaluate how insulin regulates innate immune mechanisms in the kidney’s intercalated cells. Surmounting evidence from
our research group and others suggests that intercalated cells (IC) play a critical role in antibacterial defenses against
uropathogenic E. coli (UPEC). Our research shows that insulin resistance and Type 2 diabetes mellitus increases UTI risk.
When the insulin receptor is selectively deleted in murine ICs, UPEC susceptibility significantly increases in vivo. Also,
we have demonstrated that insulin induces antimicrobial peptide (AMP) expression in primary human renal epithelial cells
via the phosphatidylinositide 3-kinase (PI3K/AKT) signaling pathway. Specifically, our data show that insulin induces
Ribonuclease 7 (RNase 7) production, the most potent AMP in the human urinary tract, to shield the urothelium from
UPEC. Together, these data provide strong support for our hypothesis that insulin signaling plays an essential role in
innate IC defenses by regulating PI3K/AKT activity and downstream AMP production. Building on these previous
studies, we propose a comprehensive analysis of insulin’s ability to regulate IC defense mechanisms. Aim 1 will evaluate
how insulin resistance and Type 2 diabetes mellitus affects IC antibacterial defenses. Aim 2 will identify how IC insulin
receptor deletion impacts AMP transcription and whether targeted PI3K/AKT activation induces AMP expression. Aim 3
will use a novel transgenic humanized mouse model to assess how insulin resistance and insulin therapy impacts the
production of RNase 7 and its antimicrobial activity in vivo. The long-term objective of this project is to improve the care
of diabetic patients with UTI by identifying novel therapeutic options. By evaluating the role of insulin signaling in host
defense, completion of these Aims can have profound influence on the health of people with diabetes as they may develop
insulin-signaling targets, like PI3K/AKT and RNase 7, as new therapeutics that prevent UTI, extending UTI treatment
options beyond the scope of antibiotics.
抽象的
糖尿病是一种增加感染易感性的全身性疾病,最常见的感染部位是糖尿病。
尿路感染 (UTI) 在患有尿路感染的人群中更为常见、更为严重,且预后更差。
迄今为止,糖尿病患者易患尿路感染的机制尚未阐明。
评估胰岛素如何调节肾脏闰细胞的先天免疫机制。
我们的研究小组和其他人表明,嵌入细胞 (IC) 在抗菌防御中发挥着关键作用
我们的研究表明,胰岛素抵抗和 2 型糖尿病会增加尿路感染风险。
当小鼠 IC 中的胰岛素受体被选择性删除时,体内 UPEC 敏感性显着增加。
我们已经证明胰岛素诱导原代人肾上皮细胞中抗菌肽(AMP)的表达
具体来说,我们的数据表明胰岛素通过磷脂酰肌醇 3 激酶 (PI3K/AKT) 信号通路诱导。
核糖核酸酶 7 (RNase 7) 的产生是人体泌尿道中最有效的 AMP,可保护尿路上皮免受
总之,这些数据为我们的假设提供了强有力的支持,即胰岛素信号在其中发挥着重要作用。
通过调节 PI3K/AKT 活性和下游 AMP 生产来实现先天 IC 防御。
研究中,我们建议对胰岛素调节 IC 防御机制的能力进行全面分析,以评估目标 1。
胰岛素抵抗和 2 型糖尿病如何影响 IC 抗菌防御能力 Aim 2 将确定 IC 胰岛素如何发挥作用。
受体缺失会影响 AMP 转录以及靶向 PI3K/AKT 激活是否会诱导 AMP 表达。
将使用新型转基因人源化小鼠模型来评估胰岛素抵抗和胰岛素治疗如何影响
RNase 7 的生产及其体内抗菌活性 该项目的长期目标是改善护理。
通过评估胰岛素信号在宿主中的作用,确定新的治疗方案,以治疗患有尿路感染的糖尿病患者。
防御,完成这些目标可能会对糖尿病患者的健康产生深远的影响,因为他们可能会发展
胰岛素信号靶标,如 PI3K/AKT 和 RNase 7,作为预防 UTI 的新疗法,延长 UTI 治疗
超出抗生素范围的选择。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John David Spencer其他文献
Urinary Tract Infections in Children
儿童尿路感染
- DOI:
10.1007/978-3-642-27843-3_49-2 - 发表时间:
2021 - 期刊:
- 影响因子:3
- 作者:
Giovanni Montini;John David Spencer;I. Hewitt - 通讯作者:
I. Hewitt
Biomarkers for urinary tract infection: present and future perspectives.
尿路感染的生物标志物:现在和未来的前景。
- DOI:
10.1007/s00467-024-06321-9 - 发表时间:
2024-03-14 - 期刊:
- 影响因子:3
- 作者:
T. Mattoo;John David Spencer - 通讯作者:
John David Spencer
Urinary Tract Infections in Children.
儿童尿路感染。
- DOI:
10.1542/pir.2023-006017 - 发表时间:
2024-05-01 - 期刊:
- 影响因子:1.3
- 作者:
Melanie C Marsh;Guillermo Yepes Junquera;Emily Stonebrook;John David Spencer;Joshua R Watson - 通讯作者:
Joshua R Watson
Current and emerging strategies to curb antibiotic-resistant urinary tract infections.
当前和新兴的遏制抗生素耐药性尿路感染的策略。
- DOI:
10.1038/s41585-024-00877-9 - 发表时间:
2024-05-07 - 期刊:
- 影响因子:0
- 作者:
Aaron Simoni;L. Schwartz;Guillermo Yepes Junquera;Christina B. Ching;John David Spencer - 通讯作者:
John David Spencer
John David Spencer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John David Spencer', 18)}}的其他基金
Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
- 批准号:
10364241 - 财政年份:2021
- 资助金额:
$ 34.2万 - 项目类别:
Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
- 批准号:
10673963 - 财政年份:2021
- 资助金额:
$ 34.2万 - 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
- 批准号:
10348147 - 财政年份:2018
- 资助金额:
$ 34.2万 - 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
- 批准号:
9883788 - 财政年份:2018
- 资助金额:
$ 34.2万 - 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
- 批准号:
9897601 - 财政年份:2018
- 资助金额:
$ 34.2万 - 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
- 批准号:
10113589 - 财政年份:2018
- 资助金额:
$ 34.2万 - 项目类别:
Novel Mouse Models to Assess the in vivo Significance of Ribonuclease 7 in Urinary Tract Defense
评估核糖核酸酶 7 在尿路防御中体内意义的新型小鼠模型
- 批准号:
9091881 - 财政年份:2016
- 资助金额:
$ 34.2万 - 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
- 批准号:
8280867 - 财政年份:2012
- 资助金额:
$ 34.2万 - 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
- 批准号:
8662257 - 财政年份:2012
- 资助金额:
$ 34.2万 - 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
- 批准号:
8662257 - 财政年份:2012
- 资助金额:
$ 34.2万 - 项目类别:
相似海外基金
Cell-free DNA as a versatile analyte for the monitoring of sepsis
游离 DNA 作为监测脓毒症的多功能分析物
- 批准号:
10665402 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Real-time Prediction of Adverse Outcomes After Surgery
实时预测手术后不良后果
- 批准号:
10724048 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Glomerular and Tubular Function in the Recovering Kidney
肾脏恢复中的肾小球和肾小管功能
- 批准号:
10587898 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别:
Patient-Derived Kidney Organoids For Modeling Kidney Injury
用于肾损伤建模的患者肾脏类器官
- 批准号:
10663719 - 财政年份:2023
- 资助金额:
$ 34.2万 - 项目类别: